Answer
Yes, hair loss (alopecia) was reported in 50.8% of patients treated with ripretinib (QINLOCK) in the pooled safety population of 392 patients.
Sources for this answer
- QINLOCK 50 mg tabletsDeciphera · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked